Pembrolizumab hits headlines as a key cancer immunotherapy advancing cures/vaccines, PD-1 blocker, Keytruda.
Benjamin Netanyahu has disclosed that a tiny, early-stage malignant tumor was found during routine monitoring after his 2024 prostate surgery and has been treated with targeted radiation. Doctors at Hadassah Medical Center have reported that follow-up imaging and blood tests show the disease has disappeared; Netanyahu says he delayed publishing his annual medical report to avoid fuelling Iranian misinformation during current hostilities.